{"slug":"pt-141-diabetic-neuropathy","verification":{"valid":true,"entries":2,"head":"ff21df4ccad5ff34d7a2da5f430f973146a2bfe1b1f42cff697fe4a7697fab51"},"energy":{"passes":2,"tokens_in":22051,"tokens_out":3370,"tokens_total":25421,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"ff21df4ccad5ff34d7a2da5f430f973146a2bfe1b1f42cff697fe4a7697fab51"},"provenance":[{"ts":"2026-06-30T01:18:18.356Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: PT 141 for Diabetic Neuropathy\nSlug: pt-141-diabetic-neuropathy\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_cross\",\"condition\":\"Diabetic neuropathy\",\"condition_key\":\"diabetic-neuropathy\",\"primary_peptide\":\"pt-141\",\"peptides_in_scope\":[{\"id\":\"pt-141\",\"name\":\"PT-141\"}],\"drugs_in_scope\":[],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down if you have Diabetic neuropathy\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"pt-141\",\"name\":\"PT-141\",\"section_title\":\"Why PT-141 might help you\",\"layer\":\"sexual / CNS arousal\",\"steps\":[\"You are reading about **Diabetic neuropathy** — what breaks down matters before any compound name.\",\"**Therefore for you:** If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue) — not because it masks pain.\"],\"prose\":\"1. You are reading about **Diabetic neuropathy** — what breaks down matters before any compound name.\\n2. **Therefore for you:** If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue) — not because it masks pain.\"}],\"drug_chains\":[],\"stimulant_chains\":[],\"stack_together\":\"Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\\n- **PT-141** → sexual / CNS arousal\",\"section_headings\":[\"What's breaking down if you have Diabetic neuropathy\",\"Why PT-141 might help you\",\"How","response":"{\n  \"slug\": \"pt-141-diabetic-neuropathy\",\n  \"title\": \"PT-141 for Diabetic Neuropathy: Evidence-Graded Review\",\n  \"body\": \"## What's breaking down if you have Diabetic neuropathy\\n\\nDiabetic neuropathy involves progressive damage to peripheral nerves driven by chronic high blood sugar. This leads to axonal degeneration, demyelination, and loss of nerve fiber density, particularly in the feet and legs. Oxidative stress, advanced glycation end products, and microvascular impairment compound the problem, reducing blood supply to nerves. Inflammatory signaling stays elevated, blocking natural repair processes. Sensory nerves often suffer first, producing burning pain, tingling, numbness, or loss of protective sensation. Autonomic nerves can be affected too, contributing to sexual dysfunction through disrupted signaling pathways in the central and peripheral nervous systems. When repair pathways cannot keep pace with this breakdown, symptoms persist and quality of life declines.\\n\\n## Why PT-141 might help you\\n\\n1. You are reading about **Diabetic neuropathy** — what breaks down matters before any compound name.\\n2. **Therefore for you:** If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue) — not because it masks pain.\\n\\nPT-141 activates melanocortin receptors (primarily MC4R) in the central nervous system. This pathway modulates arousal and desire signals. In diabetic neuropathy, sexual dysfunction frequently arises from combined vascular, neuropathic, and central processing changes. If CNS arousal circuits are impaired as part of your symptom profile, the compound's action on these receptors is the layer under discussion. It does not act as a peripheral vasodilator like PDE5 inhibitors. Instead, it engages brain pathways that can influence perception of sexual stimuli. For someone whose neuropathy intersects with reduced libido or arousal, this central mechanism is the relevant distinction from symptom-suppressing approaches.\\n","tokens_in":22051,"tokens_out":3370,"cost":0,"prev":"genesis","hash":"94d41addb13e139fecab71d70922716677f3097a461b83c0a002b2c0373a0d23"},{"ts":"2026-07-17T02:41:05.374Z","model":"owner","action":"voxel_divide","prompt":"","input":"pt-141-diabetic-neuropathy","response":"21 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"94d41addb13e139fecab71d70922716677f3097a461b83c0a002b2c0373a0d23","hash":"ff21df4ccad5ff34d7a2da5f430f973146a2bfe1b1f42cff697fe4a7697fab51"}]}